TWO SIGMA SECURITIES, LLC
Broker-DealerPosition in HALO — Halozyme Therapeutics, Inc.
CIK 1450144
NEW YORK, NY
Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$980,331
+$980,331 QoQ
Shares Held
12,525
Ownership
0.011%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#299
of 647 holders
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Sep 30, 2024CallValue
$200,340
CallShares
3,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA SECURITIES, LLC holds $22,449,685 across 103 Biotechnology names. HALO ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,761 | $3,592,213 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,585 | $1,681,252 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
17,689 | $1,317,476 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,219 | $1,191,492 | |
| 5 | INSM |
INSMED Inc
|
10,338 | $1,102,237 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
12,525 | $980,331 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,256 | $917,476 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
3,708 | $907,607 |
All Filings in HALO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $980,331 | 12,525 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $200,340 | 3,500 | Call | Sole | 2024-11-14 | |
| 2023-12-31 | $240,240 | 6,500 | Put | Sole | 2024-02-14 | |
| 2022-06-30 | $381,964 | 8,681 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||